Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

86%

6 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

6(85.7%)

Phase 1

1(14.3%)

7Total

Phase 3(6)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03004469Phase 3Completed

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

Role: lead

NCT02549001Phase 3Completed

Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis

Role: lead

NCT02547701Phase 3Completed

Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population

Role: lead

NCT02606760Phase 3Completed

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis

Role: lead

NCT03079973Phase 3Withdrawn

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s

Role: lead

NCT03094468Phase 3Withdrawn

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Role: lead

NCT02791243Phase 1Completed

Photosensitization Study in Androgenetic Alopecia

Role: lead

All 7 trials loaded